7 May 2025
Backing Secured to Prepare First Trial of Implanted Electric Field Therapy
QV Bioelectronics, developer of a first-in-class implanted Electric Field Therapy (EFT) device for brain tumours, has been awarded a £1.26 million grant under the highly…
12 March 2025
Carl Daintree Joins QV Bioelectronics as COO
Welcoming Carl to QV Bioelectronics! We’re excited to welcome Carl Daintree to the QV Bioelectronics team as the new COO! Carl has deep cross-functional experience,…
9 September 2024
QV Bioelectronics Delivers Breakthrough Pre-Clinical Safety and Efficacy Results for Electric Field Therapy in the treatment of GBM
30th August 2024, Cheshire, UK QV Bioelectronics, the creator of the world’s first implantable Electric Field Therapy (EFT) device for the treatment of brain tumours,…
30 August 2024
QV Bioelectronics secures £343,000 from Innovate UK’s Cancer Therapeutics programme to develop a new treatment for childhood brain tumours.
Press Release The project will adapt QV Bioelectronics’ existing electric field therapy (EFT) technology to develop the world’s first fully implantable EFT device to treat…
24 October 2023
QV Bioelectronics and Incubate Bio announce successful outcome of strategic collaboration to accelerate new treatment option for Glioblastoma
Collaboration delivered vital insights to advance revolutionary treatment modality – GRACE ALaSCA platform able to decipher experimental data from complex molecular pathways and simulate ‘what-if’…
10 July 2023
Michaela Joins QV as Summer Intern
Exciting News: Welcome Michaela Baek, Our New Summer Intern at QV Bioelectronics! ? Michaela, an aspiring biologist, is eager to dive into the world of…
Interested in Receiving our Press Releases?